🇺🇸 FDA
Pipeline program

JZP441

JZP441-105

Phase 1 small_molecule terminated

Quick answer

JZP441 for Narcolepsy is a Phase 1 program (small_molecule) at Jazz Pharmaceuticals plc with 1 ClinicalTrials.gov record(s).

Program details

Company
Jazz Pharmaceuticals plc
Indication
Narcolepsy
Phase
Phase 1
Modality
small_molecule
Status
terminated

Clinical trials